- Home
- DENN vs RCEL Comparison
DENN vs RCEL Comparison
Compare DENN & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DENN
- RCEL
- Stock Information
- Founded
- DENN 1953
- RCEL N/A
- Country
- DENN United States
- RCEL United States
- Employees
- DENN N/A
- RCEL N/A
- Industry
- DENN Restaurants
- RCEL Medical/Dental Instruments
- Sector
- DENN Consumer Discretionary
- RCEL Health Care
- Exchange
- DENN Nasdaq
- RCEL Nasdaq
- Market Cap
- DENN 203.4M
- RCEL 240.6M
- IPO Year
- DENN 1989
- RCEL N/A
- Fundamental
- Price
- DENN $4.09
- RCEL $6.46
- Analyst Decision
- DENN Strong Buy
- RCEL Strong Buy
- Analyst Count
- DENN 6
- RCEL 4
- Target Price
- DENN $7.46
- RCEL $17.25
- AVG Volume (30 Days)
- DENN 1.1M
- RCEL 284.1K
- Earning Date
- DENN 05-05-2025
- RCEL 05-08-2025
- Dividend Yield
- DENN N/A
- RCEL N/A
- EPS Growth
- DENN N/A
- RCEL N/A
- EPS
- DENN 0.33
- RCEL N/A
- Revenue
- DENN $453,997,000.00
- RCEL $71,661,000.00
- Revenue This Year
- DENN $6.94
- RCEL $61.20
- Revenue Next Year
- DENN $1.90
- RCEL $28.56
- P/E Ratio
- DENN $12.50
- RCEL N/A
- Revenue Growth
- DENN N/A
- RCEL 41.35
- 52 Week Low
- DENN $2.85
- RCEL $6.90
- 52 Week High
- DENN $8.30
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- DENN 53.32
- RCEL 28.05
- Support Level
- DENN $4.18
- RCEL $6.17
- Resistance Level
- DENN $4.48
- RCEL $7.43
- Average True Range (ATR)
- DENN 0.25
- RCEL 0.60
- MACD
- DENN 0.05
- RCEL -0.36
- Stochastic Oscillator
- DENN 46.34
- RCEL 7.11
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.